Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

计划入组 100 人 · 首次发布于 2023 年 5 月 6 日

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

计划入组 48 人 · 首次发布于 2017 年 4 月 19 日

The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

计划入组 100 人 · 首次发布于 2024 年 8 月 23 日

Thrombopoietin

Eltrombopag(Promacta, Revolade, Eltrombopag Accord, Eltrombopag Viatris)

C₂₅H₂₂N₄O₄ · Rx

Avatrombopag(Doptelet 60 Mg Daily Dose Carton, Doptelet)

C₂₉H₃₄Cl₂N₆O₃S₂ · Rx

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

FDA Accepts Sobi's Avatrombopag (DOPTELET®) Application for Pediatric ITP Treatment

Handok Gains Korean Approval for Doptelet to Treat ITP and CLD-Related Thrombocytopenia

FDA Grants Orphan Drug Designation to Novartis' Ianalumab for Primary Immune Thrombocytopenia